Private Label Makes Headway In Consumer Health Product Markets

More consumers around the globe are choosing private label vitamin and dietary supplements (VDS), Euromonitor reports, as companies in the sector increasingly offer high quality, value-added products that are non-GMO, gluten free, organic, vegetarian and vegan. The trend in the VDS market reflects what’s happening in consumer health generally, where the CAGR of private label products in the U.S. has reached eight percent, and 2013 retail sales of $13.9 billion, significantly outpacing consumer health industry growth. Private label health products are gaining ground in other regions, particularly Australasia and Western Europe. Price (i.e., cheapest) seems to be the main determinant in selection of OTC drugs, while quality-plus-price weigh  heavily in selection of VDS products.